Cytometric Therapeutics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
90 Park Ave Fl 29, New York, New York, 1...Revenue
<$5 MillionIndustry
About Cytometric Therapeutics
Cytometric Therapeutics Org Chart
Chief Financial Officer
Is Cytometric Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cytometric Therapeutics
Check if Cytometric Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cytometric Therapeutics launches new products
Cytometric Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cytometric Therapeutics is spiking on competitors!
Click to see if Cytometric Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Cytometric Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cytometric Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Cytometric Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cytometric Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cytometric Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cytometric Therapeutics.
Cytometric Therapeutics Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cytometric Therapeutics
Cytometric Therapeutics is developing an innovative therapy aimed at treating incurable cancer with minimal toxicity. The therapy, currently in the experimental stage, seeks to enhance the effectiveness of existing chemotherapeutic agents and has shown promise in testing on various cancer types. Founded by experienced doctors Larry Weisenthal and W... Read More